The Latest SPAC News and Rumors: September 15, 2021
by Marlena Haddad on 2021-09-15 at 11:51am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Carousell becomes Singapore’s newest unicorn, Acorns names former Amazon executive as president, and Anghami partners with Amazon Prime


Online Marketplace Carousell Is Singapore’s Newest Unicorn

Online classifieds marketplace Carousell Pte became Singapore’s latest tech unicorn, raising funds at a $1.1 billion valuation as Southeast Asia’s e-commerce startups benefit from the pandemic and related lockdowns, according to Bloomberg.

The company got $100 million in a round led by South Korean private equity firm STIC Investments.

Carousell has weighed a U.S. listing via a merger with a blank-check company, people with knowledge of the matter said in June.

READ

Acorns Names Amazon Alum David Hijirida as President Ahead of IPO

Acorns Grow Inc. hired former Amazon.com Inc. executive David Hijirida as its president, as the savings and investing startup prepares to go public by merging with a blank-check company.

On May 27, Acorns entered into a definitive agreement to combine with Pioneer Merger Corp. (NASDAQ:PACX).

READ

Amazon Prime and Anghami Collaborate in Saudi Arabia and United Arab Emirates with Anghami Plus

Amazon and Anghami have today announced that Amazon Prime members in Saudi Arabia and the UAE can enjoy an exclusive six-months free offer on Anghami Plus, Anghami’s premium paid tier, with their Prime membership.

Prime members in Saudi Arabia and the UAE will receive a free six-month subscription to Anghami Plus, followed by 50% off the subscription fee for the next six months.

On March 3, Anghami entered into a definitive agreement to combine with Vistas Media (NASDAQ:VMAC).

READ

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza  

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced the completion of enrollment in its Phase 2a clinical trial evaluating the safety and efficacy of SAB-176 in a challenge study.

SAB-176 is a novel anti-influenza human immunotherapy designed to address the limitations of current treatments for moderate to severe seasonal influenza.

On June 22, SAB announced a planned merger with Big Cypress Acquisition Corp. (NASDAQ: BCYP).

READ

Recent Posts
by Nicholas Alan Clayton on 2025-05-01 at 6:13pm

Cantor Equity Partners II, Inc. (NASDAQ:CEPT) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CEPT”, Friday, May 2, 2025. The new SPAC intends to combine with a target in the financial services, healthcare, real estate services, technology, or software industries....

by Nicholas Alan Clayton on 2025-05-01 at 5:56pm

Gores Holdings X Inc. (NASDAQ:GTENU) announced the pricing of its upsized $312 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GTENU”, Friday, May 2, 2025. The new SPAC aims to combine with a target company in the industrials, technology, healthcare, or consumer sectors. Gores X’s management team...

by Nicholas Alan Clayton on 2025-05-01 at 4:39pm

Wen Acquisition Corp. (NASDAQ:WTENNU) has filed for a $261 million SPAC to hunt for a crypto or financial services target with a team staffed by former advisors to the FinTech SPAC series. The new SPAC is not overfunded and will have a 1/2 warrant in each unit with 24 months to initially complete a business...

by Henrique Santa Rosa, CFA on 2025-05-01 at 1:49pm

April highlighted two defining trends in the SPAC market: an increased reliance on extended deadlines and a surge in announced transactions. Extension votes doubled compared to March, while the number of De-SPAC deals disclosed reached nine in April alone. These developments underscore a market that remains active but continues to rely on deadline extensions, largely...

by Nicholas Alan Clayton on 2025-05-01 at 1:38pm

D. Boral ARC Acquisition Corp. I has filed for a $250 million SPAC to be David Boral’s first in-house SPAC since the internal split at the firm formerly known as EF Hutton. Before that split, Boral and his former partner Joseph Rallo served as executive managers for the EF Hutton I SPAC, which ultimately combined...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved